Patrick C. Johnson, Md

This study tests a smartphone app called ASSIST that uses artificial intelligence to help people with breast, colorectal, or lymphoma cancer monitor and manage symptoms during chemotherapy or other systemic therapy. About 60 adults will either use the app for 12 weeks or receive …

This study tests a mobile app called THRIVE-CAR-T designed to support patients during CAR-T cell therapy. Researchers want to see if the app is easy to use and acceptable to patients. About 100 adults with blood cancer receiving CAR-T treatment will participate. The app provides …